EMA Holds Workshop on Use of Medicines in the Elderly
The European Medicines Agency (EMA) held a two-day workshop in March 2012 on the use of medicines in older persons.
The workshop saw 34 presentations covering a wide range of perspectives on the subject, including EMA's geriatric strategy, conducting clinical trials, pharmacovigilance, ensuring safety and efficacy of medicines through modeling and more.
Those presentations may be found in the links below.
European Medicines Agency workshop on medicines for older people
European Medicines Agency workshop on medicines for older people - Invitation for expressions of interest |
Programme - European Medicines Agency workshop: Ensuring safe and effective medicines for an ageing population |
Presentation - EMA Geriatric medicines strategy, Francesca Cerreta |
Presentation - Healthy ageing and medicines the patients perspective of ageing, Barbro Westerholm |
Presentation - The industrys views on geriatric medicines, Jean-Pierre Lehner |
Presentation - ICH E7 requirements and how they are translated in practice, Kristina Dunder |
Presentation - Elderly patients and clinical trials, Bertil Jonsson |
Presentation - Can PK and modelling help?, Terry Shepard |
Presentation - Modelling and simulation to support evaluation of safety and efficacy of drugs in older patients, Eva Bredberg |
Presentation - How to get better data on medicines post licensing, Thomas MacDonald |
Presentation - Endpoints and their relevance to older people: cancer and palliative care and work of EORTC, Ulrich Wedding |
Presentation - Endpoints and indications for the older population, William Evans |
Presentation - Frailty: Challenges and possible solutions, Niccolo Marchionni |
Presentation - The cluster medicine approach, Alessandra Marengoni |
Presentation - The industrys views on "older" old patients, Susanna Del Signore and Philippe Guillet |
Presentation - Increasing enrolment in clinical trials and the PREDICT study, Antonio Cherubini |
Presentation - Efficacy and effectiveness models, Graziano Onder |
Presentation - Proposal for guidance on medical research for and with older people in Europe, Florian Von Raison |
Presentation - Practical proposals on recruitment improvement: R&D approach and focus on possible bottleneck issues, Brigitte Stemper |
Presentation - Medication Errors & STOPP/START criteria, Denis O'Mahony |
Presentation - Predictors of outcome and renal clearance, Ulf Bergman |
Presentation - Pharmacovigilance and the elderly, Dolores Montero |
Presentation - EudraVigilance and signal detection, Georgy Genov |
Presentation - Industry perspective, Michael Richardson |
Presentation - Pharmacovigilance in the elderly: Conclusions, Peter Arlett |
Presentation - Formulations, packaging and medication practices considerations, Michael J. Theodorakis and Adalsteinn Gudmundsson |
Presentation - Industry perspective on formulation and packaging considerations, Ronald Ogilvie |
Presentation - What do we need to consider to ensure medication adherence of older adults, Sven Stegemann |
Presentation - Providing information to the older population - Understanding the needs of older people, Jean-Pierre Baeyens |
Presentation - A NCA analysis of approval documents, Paul Jansen |
Presentation - How can SmPC and EPAR information contribute to the safe and effective use of medicines in older population?, Laurent Brassart |
Presentation - Package leaflet initiatives, Alexios Skarlatos |
Presentation - Providing information to the older population, an industry perspective, Lisette Vromans |
Presentation - Conclusions, Tomas Salmonson, June Raine |
